Kennyhertz Perry’s Mit Winter was quoted in an article regarding California’s new law allowing college athletes to be paid for the use of their name, image, and likeness. “Law Firm
Yesterday, in a historic vote, the U.S. House of Representatives overwhelmingly passed the Secure and Fair Enforcement (“SAFE”) Banking Act (House bill HR 1595), which would essentially provide state-legal marijuana
Kennyhertz Perry, LLC Attorney Jon Dedon was recently featured on 41 Action News regarding the medical marijuana industry in Missouri. It’s currently illegal to transport marijuana seeds into the state,
It is a popular misconception that the 2018 Farm Bill legalized the interstate transportation of hemp. The 2018 Farm Bill legalized the interstate transportation of hemp only for hemp produced
CFTC Fines Registrant for Cybersecurity Violations
The FTC announced today that it sent letters to multiple companies that sell CBD products, waring them that claims they made regarding CBD violate federal law. These “warning letters” state
The Chicago Mercantile Exchange (CME) and Commodity Futures Trading Commission (CFTC) issued an Order filing and settling charges against Nathan Harris, a registered trader, for fraud, unauthorized trading, and violating
As it continues to move closer to becoming law, SB 206, the pending California bill that would allow college athletes to be compensated for the use of their names, images,
In a development that likely hinders the NCAA’s ongoing investigations into several high-profile men’s basketball programs, a federal judge has denied the NCAA’s request seeking certain materials gathered by the
The Financial Crimes Enforcement Network (“FinCEN”) unveiled its Global Investigations Division (“GID”), which will be responsible for both domestic and international investigation under the Bank Secrecy Act (“BSA”). GID will
Yesterday, the Commodity Futures Trading Commission (“CFTC”) filed a motion with the court in CFTC v. Kraft and Mondelez (15-2881 N.D. Ill.) to vacate its order setting an evidentiary hearing
The FDA could begin enforcement actions against companies that manufacture, market, or sell CBD products as soon as this fall. Previously, the FDA indicated that it was “expediting” its efforts
